Ondine Biomedical Presents at the Photodynamic Therapy Symposium 2019 (Leeds, England)
09 déc. 2019 18h46 HE
|
Ondine Biomedical Inc.
Vancouver, Canada, Dec. 09, 2019 (GLOBE NEWSWIRE) -- Ondine Biomedical Inc. announces that its President and Chief Technology Officer, Dr. Nicolas Loebel, is addressing global delegates at the...
Ondine Biomedical Inc. to Present Candida auris Program Results at the 5th International Conference on Prevention & Infection Control (ICPIC, 2019, Geneva)
06 sept. 2019 11h37 HE
|
Ondine Biomedical Inc.
Vancouver, Canada, Sept. 06, 2019 (GLOBE NEWSWIRE) -- Ondine Biomedical Inc. announces presentation of data demonstrating high levels of efficacy of its Photodisinfection program against Candida...
Yanfang Feng Honoured With 2019 Outstanding Postdoctoral Fellow Award at the 17th World Congress of the International Photodynamic Association
11 juil. 2019 15h23 HE
|
International Photodynamic Association
Boston, USA, July 11, 2019 (GLOBE NEWSWIRE) -- At the 17th International Photodynamic Association World Congress in Boston, Massachusetts, Dr. Yanfang Feng was recognized with the 2019 Outstanding...
Drs. Elizabeth Bryce, Diane Roscoe and Titus Wong Receive Significant Advancement Award at the 17th World of the International Photodynamic Association
10 juil. 2019 13h49 HE
|
International Photodynamic Association
Boston, USA, July 10, 2019 (GLOBE NEWSWIRE) -- At the 17th International Photodynamic Association World Congress in Boston, Massachusetts, Dr. Elizabeth Bryce, Dr. Diane Roscoe and Dr. Titus Wong...
Multidrug-Resistant Candida auris and Aspergillus fumigatus Eradicated by Ondine Biomedical’s antimicrobial Photodisinfection
10 avr. 2019 16h25 HE
|
Ondine Biomedical Inc.
Vancouver, BC Canada, April 10, 2019 (GLOBE NEWSWIRE) -- Ondine Biomedical Inc. announced today that its antimicrobial Photodisinfection Therapy (aPDT) successfully eradicated in laboratory testing...
ContraFect Presents New CF-301 Data at ASM Microbe 2016
21 juin 2016 07h00 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - June 21, 2016) - ContraFect Corporation (NASDAQ: CFRX) (NASDAQ: CFRXW), a biotechnology company focused on the discovery and development of protein and antibody...
ContraFect to Present at 18th Annual BIO CEO and Investor Conference
02 févr. 2016 07h00 HE
|
ContraFect Corporation
YONKERS, NY--(Marketwired - February 02, 2016) -
ContraFect Corporation
(NASDAQ: CFRX)
(NASDAQ: CFRXW), a biotechnology company focused on the discovery and...